N. Christophidis

1.4k total citations
34 papers, 1.1k citations indexed

About

N. Christophidis is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, N. Christophidis has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in N. Christophidis's work include Inflammatory mediators and NSAID effects (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). N. Christophidis is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). N. Christophidis collaborates with scholars based in Australia, United Kingdom and Barbados. N. Christophidis's co-authors include Frank Vajda, Simon Scharf, Alastair Mander, William J. Louis, Walter Cosolo, Olaf H. Drummer, W. J. Louis, Paul Martinello, George W. Mihaly and W. C. Louis and has published in prestigious journals such as The Lancet, Neurology and Clinical Chemistry.

In The Last Decade

N. Christophidis

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Christophidis Australia 16 246 237 201 196 157 34 1.1k
M. Galli-Kienle Italy 19 424 1.7× 88 0.4× 441 2.2× 186 0.9× 41 0.3× 30 1.4k
Stephanie Sanchez United States 17 240 1.0× 255 1.1× 537 2.7× 115 0.6× 52 0.3× 28 1.7k
Christine Alvey United States 22 322 1.3× 202 0.9× 268 1.3× 259 1.3× 35 0.2× 46 1.4k
Shoichi Nakagawa Japan 18 233 0.9× 85 0.4× 357 1.8× 458 2.3× 32 0.2× 48 1.9k
Mathew George Australia 15 128 0.5× 168 0.7× 228 1.1× 114 0.6× 48 0.3× 90 1.0k
Necat Yılmaz Türkiye 21 155 0.6× 90 0.4× 238 1.2× 73 0.4× 59 0.4× 85 1.2k
Thom J. Zimmerman United States 31 229 0.9× 250 1.1× 455 2.3× 64 0.3× 258 1.6× 88 3.6k
Markus Jerling Sweden 20 56 0.2× 205 0.9× 283 1.4× 235 1.2× 81 0.5× 44 1.3k
Turgut Ulutin Türkiye 17 200 0.8× 47 0.2× 309 1.5× 89 0.5× 111 0.7× 67 1.1k
PP Nawroth Germany 15 344 1.4× 84 0.4× 279 1.4× 40 0.2× 64 0.4× 44 1.3k

Countries citing papers authored by N. Christophidis

Since Specialization
Citations

This map shows the geographic impact of N. Christophidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Christophidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Christophidis more than expected).

Fields of papers citing papers by N. Christophidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Christophidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Christophidis. The network helps show where N. Christophidis may publish in the future.

Co-authorship network of co-authors of N. Christophidis

This figure shows the co-authorship network connecting the top 25 collaborators of N. Christophidis. A scholar is included among the top collaborators of N. Christophidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Christophidis. N. Christophidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vajda, Frank, et al.. (1999). Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.. PubMed. 17(3). 313–20. 96 indexed citations
2.
Scharf, Simon, et al.. (1998). NSAIDs and faecal blood loss in elderly patients with osteoarthritis: is plasma half‐life relevant?. Australian and New Zealand Journal of Medicine. 28(4). 436–439. 9 indexed citations
3.
Ioannides‐Demos, Lisa L., N. Christophidis, P. F. J. Ryan, et al.. (1997). Dosing implications of a clinical interaction between grapefruit juice and cyclosporine and metabolite concentrations in patients with autoimmune diseases.. PubMed. 24(1). 49–54. 35 indexed citations
4.
Christophidis, N., et al.. (1997). Effects of age on neutrophil function and its relevance to bacterial infections in the elderly.. PubMed. 49(1). 33–40. 11 indexed citations
5.
Christophidis, N., et al.. (1995). Gout: 'a disease of plenty'.. PubMed. 24(5). 849–51, 855. 15 indexed citations
6.
Christophidis, N., et al.. (1994). Fractures of the tibial plateau in the elderly as a cause of immobility. Australian and New Zealand Journal of Medicine. 24(6). 725–726. 6 indexed citations
7.
Cosolo, Walter, et al.. (1991). Interaction of cisplatin with other cytotoxics and non-steroidal anti-inflammatory drugs. Anti-Cancer Drugs. 2(2). 169–174. 1 indexed citations
8.
Christophidis, N., et al.. (1990). Modulation of the iodination reaction in normal human neutrophils and in whole blood by penicillamine, congeners and intracellular enzyme catalase and superoxide dismutase.. PubMed. 7(4). 365–71. 6 indexed citations
9.
Cosolo, Walter, Olaf H. Drummer, & N. Christophidis. (1989). Comparison of high-performance liquid chromatography and the Abbott Fluorescent Polarization Radioimmunoassay in the measurement of methotrexate. Journal of Chromatography B Biomedical Sciences and Applications. 494. 201–208. 13 indexed citations
10.
Drummer, Olaf H., N. Christophidis, John D. Horowitz, & William J. Louis. (1986). Measurement of penicillamine and N-acetylcysteine in human blood by high-performance liquid chromatography and electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 374(2). 251–257. 22 indexed citations
11.
Christophidis, N., et al.. (1986). Pharmacodynamics and pharmacokinetics in the elderly.. PubMed. 15(2). 194–5. 1 indexed citations
12.
Christophidis, N., et al.. (1986). ACUTE AND CHRONIC PHARMACOKINETIC STUDIES OF SLOW RELEASE KETOPROFEN (ORUVAIL) IN RHEUMATOID ARTHRITIS. Clinical and Experimental Pharmacology and Physiology. 13(7). 555–561. 7 indexed citations
13.
Christophidis, N. & W. J. Louis. (1983). Benoxaprofen. The Medical Journal of Australia. 2(3). 114–115. 1 indexed citations
14.
Christophidis, N., et al.. (1981). Renal clearance of methotrexate in man during high-dose oral and intravenous infusion therapy. Cancer Chemotherapy and Pharmacology. 6(1). 59–64. 20 indexed citations
15.
Horowitz, John D., L. G. Howes, N. Christophidis, et al.. (1980). HYPERTENSIVE RESPONSES INDUCED BY PHENYLPROPANOLAMINE IN ANORECTIC AND DECONGESTANT PREPARATIONS. The Lancet. 315(8159). 60–61. 71 indexed citations
16.
Christophidis, N., et al.. (1979). Comparison of intravenous and oral high-dose methotrexate in treatment of solid tumours.. BMJ. 1(6159). 298–300. 18 indexed citations
17.
Christophidis, N., et al.. (1979). Ocular Side Effects with 5‐Fluorouracil. Australian and New Zealand Journal of Medicine. 9(2). 143–144. 35 indexed citations
18.
McNeil, John J., A. Anderson, N. Christophidis, Bevyn Jarrott, & William J. Louis. (1979). Taste loss associated with captopril treatment.. BMJ. 2(6204). 1555.2–1556. 35 indexed citations
19.
Christophidis, N., J. K. Dawborn, & Frank Vajda. (1978). STUDIES OF INTRAVENOUS CEFOXITIN (MK306). The Medical Journal of Australia. 1(9). 512–514. 3 indexed citations
20.
Christophidis, N., et al.. (1978). Fluorouracil Therapy in Patients With Carcinoma of the Large Bowel. Clinical Pharmacokinetics. 3(4). 330–336. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Galli-Kienle Breakdown of academic impact, for papers by Stephanie Sanchez Breakdown of academic impact, for papers by Christine Alvey Breakdown of academic impact, for papers by Shoichi Nakagawa Breakdown of academic impact, for papers by Mathew George Breakdown of academic impact, for papers by Necat Yılmaz Breakdown of academic impact, for papers by Thom J. Zimmerman Breakdown of academic impact, for papers by Markus Jerling Breakdown of academic impact, for papers by Turgut Ulutin Breakdown of academic impact, for papers by PP Nawroth
Rankless by CCL
2026